These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 6186079

  • 1. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
    Vedbrat SS, Rasheed S, Lutz H, Gonda MA, Ruscetti S, Gardner MB, Prensky W.
    Virology; 1983 Jan 30; 124(2):445-61. PubMed ID: 6186079
    [Abstract] [Full Text] [Related]

  • 2. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
    Snyder HW, Singhal MC, Zuckerman EE, Jones FR, Hardy WD.
    Virology; 1983 Dec 30; 131(2):315-27. PubMed ID: 6318434
    [Abstract] [Full Text] [Related]

  • 3. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.
    Stephenson JR, Essex M, Hino S, Hardy WD, Aaronson SA.
    Proc Natl Acad Sci U S A; 1977 Mar 30; 74(3):1219-23. PubMed ID: 191832
    [Abstract] [Full Text] [Related]

  • 4. Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein.
    Stephenson JR, Khan AS, Sliski AH, Essex M.
    Proc Natl Acad Sci U S A; 1977 Dec 30; 74(12):5608-12. PubMed ID: 202959
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.
    Sherr CJ, Todaro GJ, Sliski A, Essex M.
    Proc Natl Acad Sci U S A; 1978 Sep 30; 75(9):4489-93. PubMed ID: 212755
    [Abstract] [Full Text] [Related]

  • 6. Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.
    Sherr CJ, Sen A, Todaro GJ, Sliski A, Essex M.
    Proc Natl Acad Sci U S A; 1978 Mar 30; 75(3):1505-9. PubMed ID: 206902
    [Abstract] [Full Text] [Related]

  • 7. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK, de Noronha F, Tusch C, Michalek MT, McLane MF.
    J Natl Cancer Inst; 1980 Dec 30; 65(6):1285-92. PubMed ID: 6253714
    [Abstract] [Full Text] [Related]

  • 8. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A, Grófová M.
    Neoplasma; 1983 Dec 30; 30(3):281-6. PubMed ID: 6306490
    [Abstract] [Full Text] [Related]

  • 9. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H, Pedersen NC, Theilen GH.
    Am J Vet Res; 1983 Nov 30; 44(11):2054-9. PubMed ID: 6316819
    [Abstract] [Full Text] [Related]

  • 10. Leukemia specific antigens: FOCMA and immune surveillance.
    Essex M, Grant CK, Cotter SM, Sliski AH, Hardy WD.
    Haematol Blood Transfus; 1979 Nov 30; 23():453-86. PubMed ID: 232469
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
    Chen AP, Essex ME.
    Cancer Invest; 1984 Nov 30; 2(2):81-90. PubMed ID: 6329486
    [Abstract] [Full Text] [Related]

  • 13. Humoral immune responses of cats to feline leukemia virus: comparison of responses to the major structural protein p30 and to a virus-specific cell membrane antigen (FOCMA).
    Charman HP, Kim N, Gilden RV, Hardy WD, Essex M.
    J Natl Cancer Inst; 1976 Apr 30; 56(4):859-61. PubMed ID: 176414
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
    Schaller JP, Mathes LE, Hoover EA, Olsen RG.
    Int J Cancer; 1979 Nov 15; 24(5):700-5. PubMed ID: 93586
    [Abstract] [Full Text] [Related]

  • 15. Studies on antibodies against feline leukaemia virus (FeLV) in cat sera and rabbit anti-FeLV sera: cross reaction and differences.
    Calafat J, Weijer K, Hageman PC, Daams H.
    J Gen Virol; 1979 Oct 15; 45(1):217-22. PubMed ID: 93140
    [Abstract] [Full Text] [Related]

  • 16. Feline oncornavirus-associated cell membrane antigen: expression in transformed nonproducer mink cells.
    Sliski AH, Essex M, Meyer C, Todaro G.
    Science; 1977 Jun 17; 196(4296):1336-9. PubMed ID: 194310
    [Abstract] [Full Text] [Related]

  • 17. Immune response to leukemia virus and tumor-associated antigens in cats.
    Essex M, Sliski A, Hardy WD, Cotter SM.
    Cancer Res; 1976 Feb 17; 36(2 pt 2):640-5. PubMed ID: 56224
    [Abstract] [Full Text] [Related]

  • 18. Infection of feline embryo adherent cells with feline leukemia virus: feline oncornavirus-associated cell membrane antigen expression and morphologic transformation.
    Rice JB, Schaller JP, Lewis MG, Mathes LE, Hoover EA, Olsen RG.
    J Natl Cancer Inst; 1981 Jan 17; 66(1):89-96. PubMed ID: 6256575
    [Abstract] [Full Text] [Related]

  • 19. Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibody.
    Grant CK, Michalek MT.
    Int J Cancer; 1981 Aug 15; 28(2):209-17. PubMed ID: 6172390
    [Abstract] [Full Text] [Related]

  • 20. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K, Pfauth A, van Herwijnen R, Jarrett O, Meloen RH, Tomee C, Osterhaus AD.
    Vaccine; 1993 Aug 15; 11(9):946-56. PubMed ID: 7692683
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.